Remdesivir report sparks more debate on drug price value
How much should remdesivir cost? This question puts two drug-value organizations at odds. More
Video: Science’s Viral Misinformation
Watch the video of Shannon Brownlee and Jeanne Lenzer discussing pandemic misinformation in a Future Tense conversation. More
Paying attention to the mental health effects of lockdown
Even though we have saved lives by locking down, we still have to address the effects of this decision on our country's mental health. More
Pharma sales reps still visiting doctors in the pandemic
Visits from pharmaceutical sales reps haven't stopped during the pandemic--they've just moved online... More
How to have a public health internship during a pandemic
Brooke McNaughton shares what she learned as a Lown public health intern during an unprecedented health crisis. More
Clunky EHRs hinder Covid-19 response
Like so many other aspects of our health care system, the pandemic has laid bare the flaws in our electronic health record system. More
VIDEO: Are hospitals collaborating during Covid-19?
During this unprecedented health crisis, what will it take for hospitals to put aside their rivalries and work together? Shannon Brownlee and Vikas Saini discuss in the latest edition of "Lown Hospitals Q&A." More
Key questions about remdesivir still unanswered
Since the release of the initial NIH study results, clinicians and researchers have posed many questions about remdesivir, which have so far gone unanswered. Here are a few of them... More
Reduced cancer screenings in Covid-19
A study found that preventive cancer screenings sharply declined due to Covid-19. What effect will this dramatic decline in screening have on patient health? More
Contact tracing: Are we doing enough?
Some states are ramping up their contact tracing capacity-- but are they hiring enough tracers to open up safely? More